Suppr超能文献

完全切除侵犯胸壁的非肺上沟癌后的预后因素。

Prognostic factors following complete resection of non-superior sulcus lung cancer invading the chest wall.

作者信息

Jones Gregory D, Caso Raul, No Jae Seong, Tan Kay See, Dycoco Joseph, Bains Manjit S, Rusch Valerie W, Huang James, Isbell James M, Molena Daniela, Park Bernard J, Jones David R, Rocco Gaetano

机构信息

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Weill Cornell Medical College, New York, NY, USA.

出版信息

Eur J Cardiothorac Surg. 2020 Jul 1;58(1):78-85. doi: 10.1093/ejcts/ezaa027.

Abstract

OBJECTIVES

Locally advanced non-small-cell lung cancer (NSCLC) with chest wall invasion carries a high risk of recurrence and portends poor survival (30-40% and 20-50%, respectively). No studies have identified prognostic factors in patients who underwent R0 resection for non-superior sulcus NSCLC.

METHODS

A retrospective review was conducted for all chest wall resections for NSCLC from 2004 to 2018. Patients with superior sulcus tumours, partial (<1 rib) or incomplete (R1/R2) resection or distant metastasis were excluded. Disease-free survival (DFS) and overall survival (OS) were estimated using the Kaplan-Meier method. Cox proportional hazards modelling was used to determine factors associated with DFS and OS.

RESULTS

A total of 100 patients met inclusion criteria. Seventy-three (73%) patients underwent induction therapy, and all but 12 (16%) patients experienced a partial radiological response. A median of 3 ribs was resected (range 1-7), and 67 (67%) patients underwent chest wall reconstruction. The 5-year DFS and OS were 36% and 45%, respectively. Pathological N2 status [hazard ratio (HR) 3.12, confidence interval (CI) 1.56-6.25; P = 0.001], intraoperative blood transfusion (HR 2.24, CI 1.28-3.92; P = 0.005) and preoperative forced vital capacity (per % forced vital capacity, HR 0.97, CI 0.96-0.99; P = 0.013) were associated with DFS. Increasing pathological stage, lack of radiological response to induction therapy (HR 7.35, CI 2.35-22.99; P = 0.001) and cardiovascular comorbidity (HR 2.43, CI 1.36-4.36; P = 0.003) were associated with OS.

CONCLUSIONS

We demonstrate that blood transfusion and forced vital capacity are associated with DFS after R0 resection for non-superior sulcus NSCLC, while radiological response to induction therapy greatly influences OS. We confirm that pathological nodal status and pathological stage are reproducible determinants of DFS and OS, respectively.

摘要

目的

局部晚期非小细胞肺癌(NSCLC)侵犯胸壁时复发风险高,预后较差(分别为30 - 40%和20 - 50%)。尚无研究确定非肺上沟NSCLC行R0切除患者的预后因素。

方法

对2004年至2018年所有因NSCLC行胸壁切除的患者进行回顾性分析。排除肺上沟肿瘤、部分(<1根肋骨)或不完全(R1/R2)切除或远处转移的患者。采用Kaplan-Meier法估计无病生存期(DFS)和总生存期(OS)。使用Cox比例风险模型确定与DFS和OS相关的因素。

结果

共有100例患者符合纳入标准。73例(73%)患者接受了诱导治疗,除12例(16%)外,所有患者均有部分影像学缓解。平均切除3根肋骨(范围1 - 7),67例(67%)患者接受了胸壁重建。5年DFS和OS分别为36%和45%。病理N2状态[风险比(HR)3.12,置信区间(CI)1.56 - 6.25;P = 0.001]、术中输血(HR 2.24,CI 1.28 - 3.92;P = 0.005)和术前用力肺活量(每%用力肺活量,HR 0.97,CI 0.96 - 0.99;P = 0.013)与DFS相关。病理分期增加、诱导治疗无影像学缓解(HR 7.35,CI 2.3

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a32/7305839/433a09fb0e84/ezaa027f3.jpg

相似文献

1
Prognostic factors following complete resection of non-superior sulcus lung cancer invading the chest wall.
Eur J Cardiothorac Surg. 2020 Jul 1;58(1):78-85. doi: 10.1093/ejcts/ezaa027.
2
The prognostic factors of resected non-small cell lung cancer with chest wall invasion.
World J Surg Oncol. 2012 Jan 12;10:9. doi: 10.1186/1477-7819-10-9.
3
Prognostic factors after complete resection of pN2 non-small cell lung cancer.
J Thorac Cardiovasc Surg. 2013 Oct;146(4):788-95. doi: 10.1016/j.jtcvs.2013.04.043. Epub 2013 Jun 27.
4
Induction chemoradiation is associated with improved survival in chest wall invasion lung cancer.
Tumori. 2019 Aug;105(4):331-337. doi: 10.1177/0300891619839283. Epub 2019 Mar 25.
5
Patterns of Failure After Surgery for Non-Small-cell Lung Cancer Invading the Chest Wall.
Clin Lung Cancer. 2017 Jul;18(4):e259-e265. doi: 10.1016/j.cllc.2016.11.008. Epub 2016 Nov 21.
6
Resection of chest wall invasion in patients with non-small cell lung cancer.
Eur J Cardiothorac Surg. 2004 Dec;26(6):1200-4. doi: 10.1016/j.ejcts.2004.07.038.
7
Factors affecting long-term survival after en-bloc resection of lung cancer invading the chest wall.
Eur J Cardiothorac Surg. 2000 Nov;18(5):513-8. doi: 10.1016/s1010-7940(00)00537-6.
9
Postoperative Radiotherapy for Surgically Resected ypN2 Non-Small Cell Lung Cancer.
Ann Thorac Surg. 2018 Sep;106(3):848-855. doi: 10.1016/j.athoracsur.2018.04.064. Epub 2018 May 26.
10
Nodal stage of surgically resected non-small cell lung cancer and its effect on recurrence patterns and overall survival.
Int J Radiat Oncol Biol Phys. 2015 Mar 15;91(4):765-73. doi: 10.1016/j.ijrobp.2014.12.028.

引用本文的文献

1
Long-term outcome and prognostic factors after chest wall resection and reconstruction.
Interdiscip Cardiovasc Thorac Surg. 2025 Jun 4;40(6). doi: 10.1093/icvts/ivaf126.
2
Chest wall resections for non-small cell lung cancer: a literature review.
J Thorac Dis. 2024 Jul 30;16(7):4794-4806. doi: 10.21037/jtd-23-774. Epub 2024 Jul 26.
3
Biologic versus synthetic prosthesis for chest wall reconstruction: a matched analysis.
Eur J Cardiothorac Surg. 2023 Dec 1;64(6). doi: 10.1093/ejcts/ezad348.
5
Expert consensus on resection of chest wall tumors and chest wall reconstruction.
Transl Lung Cancer Res. 2021 Nov;10(11):4057-4083. doi: 10.21037/tlcr-21-935.
8
Extended resections and other special cases in lung cancer surgery: Real-world population-based outcomes.
Thorac Cancer. 2020 Oct;11(10):2932-2940. doi: 10.1111/1759-7714.13638. Epub 2020 Sep 1.

本文引用的文献

1
Induction chemoradiation is associated with improved survival in chest wall invasion lung cancer.
Tumori. 2019 Aug;105(4):331-337. doi: 10.1177/0300891619839283. Epub 2019 Mar 25.
2
Perioperative blood transfusion has a dose-dependent relationship with disease recurrence and survival in patients with non-small cell lung cancer.
J Thorac Cardiovasc Surg. 2019 Jun;157(6):2469-2477.e10. doi: 10.1016/j.jtcvs.2018.12.109. Epub 2019 Feb 12.
4
Surgical Management of Lung Cancer Involving the Chest Wall.
Thorac Surg Clin. 2017 May;27(2):195-199. doi: 10.1016/j.thorsurg.2017.01.013.
5
7
Perioperative blood transfusion is associated with worse clinical outcomes in resected lung cancer.
Ann Thorac Surg. 2014 May;97(5):1827-37. doi: 10.1016/j.athoracsur.2013.12.044. Epub 2014 Mar 25.
8
Review of chest wall tumors: a diagnostic, therapeutic, and reconstructive challenge.
Semin Plast Surg. 2011 Feb;25(1):16-24. doi: 10.1055/s-0031-1275167.
10
Non-small cell lung cancer invading the chest wall.
Thorac Surg Clin. 2010 Nov;20(4):519-27. doi: 10.1016/j.thorsurg.2010.06.004.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验